Ameritas Advisory Services LLC reduced its stake in Thermo Fisher Scientific Inc. (NYSE:TMO – Free Report) by 19.8% during ...

Gastric cancer diagnostics companies are Abbott, BD, Bio-Rad Laboratories, Roche, Siemens Healthineers, Thermo Fisher Scientific, Pillar Biosciences, ETC ...

Thermo Fisher Scientific Inc (TMO) stock saw a decline, ending the day at $559.65 which represents a decrease of $-2.06 or -0.37% from the prior close of $561.71. The stock opened at $562.46 and ...

The global single-use assemblies market, valued at US$ 2.52 billion in 2023, is forecasted to grow at a robust CAGR of 13.2%, reaching US$ 2.63 ...

Senator Elizabeth Warren has called on President-elect Trump's defense secretary pick, Pete Hegseth, to divest from thousands ...

Ribometrix, a spinout of UNC-Chapel Hill, has named William Marshall as its new CEO, succeeding former chief executive ...

Antimicrobial Resistance Diagnostics market is growing rapidly due to the high prevalence of antimicrobial resistance and the critical need. VANCOUVER, BRI ...

CMB International Securities analyst Jill Wu has maintained their bullish stance on WXIBF stock, giving a Buy rating on January 13.Stay Ahead ...

Shares of Thermo Fisher Scientific Inc. TMO rose 1.86% to $561.71 Thursday, on what proved to be an all-around rough trading ...

Thermo Fisher Scientific Inc (TMO) stock saw a decline, ending the day at $551.47 which represents a decrease of $-5.52 or -0.99% from the prior close of $556.99. The stock opened at $557.88 and ...

Highlights from the first day included updates from several firms about their China businesses and M&A strategies.

Lyndra Therapeutics and Thermo Fisher Scientific have entered a strategic partnership for Lyndra's long-acting oral therapies ...